Mistral Therapeutics

Mistral Therapeutics is a biotechnology company focused on developing innovative therapies for the treatment of fibrosis. Founded in 2011 and based in San Diego, California, the company aims to address the needs of patients suffering from fibrotic diseases through breakthrough first-in-class and clinically proven best-in-class mechanisms. By leveraging world-class expertise in fibrosis, Mistral Therapeutics seeks to enable quicker treatment initiation and improve the likelihood of successful outcomes for patients. As a subsidiary of Inception Sciences, the company is dedicated to advancing its drug development initiatives to meet critical health challenges associated with fibrotic disorders.